Table 21: Dataset - stage complete

Completeness of the dataset (%) - stage complete by cancer site groups summary (persons)
Country average (population) Country average (country) England Scotland Northern Ireland Wales Republic of Ireland
All invasive xnmsc 80.6% 77.9% 81.9% 67.2% 84.7%
Haematology 67.0% 50.6% 71.9% 0.0% 79.9%
Head and Neck 88.6% 86.6% 89.9% 76.8% 93.2%
Lower GI 88.8% 84.8% 90.4% 73.6% 90.5%
Upper GI 80.6% 72.6% 82.5% 67.8% 67.5%
HPB 71.0% 72.6% 70.7% 72.9% 74.3%
Trachea, Bronchus & Lung 93.2% 93.2% 93.4% 91.7% 94.6%
Melanoma of skin 89.8% 77.2% 94.6% 38.8% 98.2%
Breast 92.7% 91.4% 93.4% 84.8% 96.1%
Cervix 92.7% 95.6% 92.1% 95.9% 98.8%
Other Female Genitals 86.7% 86.1% 87.5% 76.0% 94.8%
Prostate 90.0% 89.4% 90.3% 84.3% 93.6%
Bladder 84.9% 79.3% 87.4% 59.2% 91.4%
Kidney 86.2% 85.4% 87.1% 74.1% 95.0%
Thyroid and other endocrine glands 72.1% 82.6% 70.7% 78.9% 98.1%
Other invasive cancer 62.5% 51.6% 66.3% 25.4% 63.1%
Non-Melanoma Skin Cancer 4.2% 5.3% 4.3% 0.0% 11.7%